Antineoplastic agents: Spain public contracts since 2024

Updated 12 October 2026 · all lines

Antineoplastic agents: Spain public contracts since 2024. Since January 2024 the line carries 158 award notices from 17 buyers. 127 suppliers share it. 27 in 2024. 63 in 2025. 68 in the first 9 months of 2026. 37 of them had no award notice in the register from November 2023 to 2024.

Assay record ASY-ES-0D4I3F41FJ · Cite as: Assay Systems, “Antineoplastic agents: Spain public contracts since 2024”, https://assay-systems.com/register/es/line/antineoplastic-agents/

The line

Since January 2024 the line carries 158 award notices from 17 buyers. 127 suppliers share it.

27 in 2024. 63 in 2025. 68 in the first 9 months of 2026.

37 of them had no award notice in the register from November 2023 to 2024.

Suppliers in the line, by award notices since 2024

3 more suppliers in the line are not listed here, because their register name may be the name of a private person.

The extract for this line

Names every buyer behind the figures and, for each award notice, the supplier, the award date, the notice number and the value where one is disclosed, and the notices behind every figure.

Request extract Ask about this line

Largest suppliers in the line

Share of the line held by each of its largest suppliers, by number of award notices, in the TED register for Spain.

GILEAD SCIENCES, S.L.51.3%JANSSEN-CILAG, S.A.18.4%NOVARTIS FARMACEUTICA, S.A.7.6%AMGEN, S.A.6.3%GLAXOSMITHKLINE, S.A.4.4%BRISTOL-MYERS SQUIBB, S.A.U.3.8%LILLY, S.A.3.8%PFIZER, S.L.U.3.8%ROCHE FARMA, S.A.3.8%SANOFI AVENTIS, S.A.3.8%

All suppliers in Spain, A to Z

Source: contract award notices for Spain in Tenders Electronic Daily (TED), Publications Office of the European Union, ted.europa.eu, reusable for commercial purposes under Commission Decision 2011/833/EU; notices from November 2023, when TED began to publish the winning supplier, to 30 September 2026, accessed 11 October 2026.Assay Systems has changed the data.